angiotensin ii has been researched along with carbonyl 3-chlorophenylhydrazone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Chen, F; Fu, GS; Hu, SJ; Hu, XS; Mou, Y; Sun, ZW; Tao, W; Wang, RH; Wu, YT; Xiao, FQ | 1 |
1 other study(ies) available for angiotensin ii and carbonyl 3-chlorophenylhydrazone
| Article | Year |
|---|---|
Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Autophagy; beta-Galactosidase; Cellular Senescence; DNA Fragmentation; Endothelial Cells; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Hydrazones; Membrane Potential, Mitochondrial; Mitochondria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2014 |